Perfusion Index Parameter
Verification of a Perfusion Index Parameter in Adult Volunteers
1 other identifier
observational
32
1 country
1
Brief Summary
To evaluate the association between the Perfusion index parameter and an independent measure of perfusion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 4, 2024
CompletedStudy Start
First participant enrolled
September 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 13, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 13, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedOctober 26, 2024
September 1, 2024
9 days
September 4, 2024
October 23, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Perfusion Index (PI) correlation to doppler measurement
To confirm correlation of Perfusion Index measured by the investigational pulse oximeter PCBA and Market Released sensors to the laser doppler measure of skin perfusion (LDSP) as determined by an overall instantaneous (lag(0)) Spearman rank correlation.
1 hour
Study Arms (1)
Healthy Volunteers
Eligibility Criteria
Healthy Male or Female volunteers age ≥18 years, weighing greater than 40kgs.
You may qualify if:
- Subjects ≥18 years of age
- Subject is able to participate for the duration of the study
- Subject is willing to sign an informed consent
- Subject weighs \>40kg
You may not qualify if:
- Previous injury or trauma to fingers or hands that may change blood flow or vascular supply and affect the ability to test sensors
- Physiologic abnormalities that prevent proper application of pulse oximetry sensor
- Severe contact allergies that cause a reaction to standard adhesive materials such as those found in medical sensors and electrodes.
- Raynaud Syndrome
- Repeated systolic blood pressure \> 140mmHg -
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medtronic - MITGlead
Study Sites (1)
Medtronic Clinical Physiology Lab
Denver, Colorado, 80218, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Randall M Clark, M.D.
Medtronic Clinical Physiology Lab
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 4, 2024
First Posted
September 19, 2024
Study Start
September 4, 2024
Primary Completion
September 13, 2024
Study Completion
September 13, 2024
Last Updated
October 26, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share